Scientists test new Nose-Drop vaccines to protect babies from RSV
NCT ID NCT03596801
Summary
This early-stage study tested two new experimental vaccines designed to protect against Respiratory Syncytial Virus (RSV) in young children. The vaccines were given as nose drops to 60 children, including some who had never had RSV before. The main goals were to check if the vaccines were safe, if they caused a mild infection to trigger immunity, and if they prompted the body to produce protective antibodies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RSV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Johns Hopkins University Center for Immunization Research
Baltimore, Maryland, 21205, United States
Conditions
Explore the condition pages connected to this study.